Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104,208 | 78,446 | 62,031 | 196,642 | 79,442 |
| Marketable Securities | 173,933 | 215,154 | 124,579 | N/A | N/A |
| TOTAL | $280,101 | $296,697 | $189,058 | $199,228 | $80,230 |
| Non-Current Assets | |||||
| PPE Net | 1,969 | 1,981 | 1,893 | 1,978 | 2,096 |
| Other Non-Current Assets | 1,890 | 319 | 711 | 319 | 2,730 |
| TOTAL | $3,859 | $2,300 | $2,604 | $2,297 | $4,826 |
| Total Assets | $283,960 | $298,997 | $191,662 | $201,525 | $85,056 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 606 | 757 | 1,598 | 1,389 | 770 |
| TOTAL | $7,676 | $9,002 | $6,928 | $5,778 | $4,780 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 209 | 219 | 0 | 0 | 178,058 |
| TOTAL | $209 | $219 | $359 | $500 | $178,693 |
| Total Liabilities | $7,885 | $9,221 | $7,287 | $6,278 | $183,473 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,696 | 36,695 | 30,838 | 29,956 | 29,903 |
| Common Shares | 4 | 4 | 3 | 3 | N/A |
| Retained earnings | -182,902 | -166,393 | -138,134 | -112,586 | -101,562 |
| Other shareholders' equity | 17 | -31 | -29 | 0 | 0 |
| TOTAL | $276,075 | $289,776 | $184,375 | $195,247 | $-98,417 |
| Total Liabilities And Equity | $283,960 | $298,997 | $191,662 | $201,525 | $85,056 |